Sartorius Stedim Biotech S.A.
SRTOY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $219,200 | $309,700 | $1,130,400 | $646,720 |
| Dep. & Amort. | $301,700 | $237,600 | $181,700 | $141,556 |
| Deferred Tax | $0 | $0 | $0 | -$900 |
| Stock-Based Comp. | $0 | $0 | $0 | $900 |
| Change in WC | $251,000 | $190,700 | -$351,300 | -$145,755 |
| Other Non-Cash | $43,200 | -$108,300 | -$348,500 | $53,450 |
| Operating Cash Flow | $815,100 | $629,700 | $612,300 | $695,971 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$339,800 | -$473,600 | -$430,600 | -$323,987 |
| Net Acquisitions | $0 | -$2,240,900 | -$515,600 | -$141,671 |
| Inv. Purchases | -$100 | $0 | $0 | -$323,987 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $323,987 |
| Other Inv. Act. | -$100 | -$8,200 | -$11,300 | $432 |
| Investing Cash Flow | -$340,000 | -$2,722,700 | -$957,500 | -$465,226 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$861,900 | $2,322,800 | $392,400 | -$5,468 |
| Stock Issued | $1,193,600 | $1,300 | $0 | $0 |
| Stock Repurch. | -$1,900 | $0 | -$3,200 | $0 |
| Dividends Paid | -$67,100 | -$132,700 | -$116,100 | -$62,683 |
| Other Fin. Act. | -$177,800 | -$205,300 | -$52,400 | -$9,549 |
| Financing Cash Flow | $84,900 | $1,986,100 | $220,700 | -$71,711 |
| Forex Effect | $2,300 | -$300 | $8,000 | $4,831 |
| Net Chg. in Cash | $562,300 | $9,500 | -$116,500 | $163,864 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $116,600 | $107,100 | $223,600 | $59,762 |
| End Cash | $678,900 | $116,600 | $107,100 | $223,626 |
| Free Cash Flow | $475,300 | $156,100 | $181,700 | $371,984 |